Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables RefundsShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Viemed Healthcare (VMD) Depreciation & Amortization (IS) (2023 - 2026)

Viemed Healthcare filings provide 3 years of Depreciation & Amortization (IS) readings, the most recent being $387000.0 for Q4 2025.

  • On a quarterly basis, Depreciation & Amortization (IS) rose 12.83% to $387000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $1.5 million, a 0.13% change, with the full-year FY2025 number at $1.5 million, changed 0.13% from a year prior.
  • Depreciation & Amortization (IS) hit $387000.0 in Q4 2025 for Viemed Healthcare, down from $397000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (IS) ranged from a high of $434000.0 in Q4 2023 to a low of $240000.0 in Q1 2023.
  • Median Depreciation & Amortization (IS) over the past 3 years was $365000.0 (2024), compared with a mean of $363250.0.
  • The widest YoY moves for Depreciation & Amortization (IS): up 72.92% in 2024, down 20.97% in 2024.
  • Viemed Healthcare's Depreciation & Amortization (IS) stood at $434000.0 in 2023, then dropped by 20.97% to $343000.0 in 2024, then grew by 12.83% to $387000.0 in 2025.
  • The last three reported values for Depreciation & Amortization (IS) were $387000.0 (Q4 2025), $397000.0 (Q3 2025), and $353000.0 (Q2 2025) per Business Quant data.